Academic Highlights: Review of the Pharmacologic Management of Depression.[CME]
J Clin Psychiatry 2006;67(3):478-489
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Click to enlarge page
Michael E. Thase, M.D., began his presentation by stating that remission can be defined as a virtually complete relief of symptoms; that is, a level of symptoms basically indistinguishable from that of someone who has never been depressed. In depression, remission is usually understood to mean the optimal level of improvement for the acute phase treatment of an episode of major depressive disorder. Being in remission means that the individual has been able to return to a normal level of social functioning.